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Focal slow wave activitya b s t r a c t
Objective: EEG value in possible transient ischemic attacks (TIA) is unknown. We aim to quantify focal
slow wave activity (FSWA) and epileptiform activity (EA) frequency in possible TIA, and to analyse its
contribution to the final diagnosis of seizures and/or definitive TIA.
Methods: Prospective longitudinal study of possible TIA patients evaluated at a tertiary centre during 36
months and with 1–3 months follow-up. EEG was performed as soon as possible (early EEG) and one
month later (late EEG). A stroke neurologist established final diagnosis after reassessing all clinical and
diagnostic tests.
Results: 80 patients underwent an early EEG (45.8 h after possible TIA): 52 had FSWA and 6 of them also
EA. Early FSWA was associated with epileptic seizure or definitive TIA final diagnosis (p = .041). Patients
with these diagnoses had more frequently early FSWA (19/23; 82.6%) than EA (6/23; 26.1%). 6/13 (46.2%)
patients with epileptic seizure final diagnosis had EA.
Results: In the late EEG, 43 (58.1%) patients demonstrated persistent FSWA and 3 of them also EA.
Persistent FSWA in the late EEG was more frequent in seizures than in TIA patients (91.7% vs. 45.5%).
FSWA disappearance was associated with acute vascular lesion on neuroimage.
Conclusions: FSWA was the commonest EEG abnormality found in the early EEG of patients with possible
TIA, but did not distinguish between TIA and seizure patients. In patients with seizures, FSWA was more
common than EA and its presence in the late EEG was more likely in patients with epileptic seizures than
with TIA.
Significance: The majority of possible TIA patients with the final diagnosis of epileptic seizures do not
have EA in the early or late EEG.
 2017 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Neurological syndromes lasting less than 24 h include not only
Transient Ischemic Attacks (TIA) but also other clinical entities
such as epileptic seizures. The differential diagnosis between a
transient ischaemic attack (TIA), an epileptic seizure or other tran-sient neurological disturbances can be challenging and depends on
the clinician’s expertise (Calanchini et al., 1977; Castle et al., 2010;
Ferro et al., 1996; Fonseca and Canhão, 2011; Kraaijeveld et al.,
1984; Prabhakaran et al., 2008) and also on the available clinical
information (Beniczky et al., 2012; Deacon et al., 2003; Fonseca
and Canhão, 2011; Jin et al., 2014; Prabhakaran et al., 2008).
After extensive clinical investigation, approximately one-fourth
of TIA patients are only labelled as ‘‘probable” or ‘‘possible TIA”
(Fonseca and Canhão, 2011; Prabhakaran et al., 2008), defined as
a clinical syndrome lasting less than 24 h that do not fulfil accepted
criteria for TIA nor for another diagnosis, although a vascular origin
cannot be excluded (Correia et al., 2015; Fonseca and Canhão,
2011). The main reasons for classification difficulties of possible
TIA include odd accompanying symptoms (such as prickles/itching
12 C. Bentes et al. / Clinical Neurophysiology Practice 3 (2018) 11–19sensations, rigid postures or movement of the limbs), march of
symptoms, consciousness disturbance or amnesia with focal symp-
toms, multiple stereotyped episodes, positive visual phenomena,
isolated speech disturbance/confusion and focal symptoms plus
panic or anxiety and paucity of details in the symptoms description
(Fonseca and Canhão, 2011).
Diagnostic challenges between a TIA and an epileptic seizure
include non-convulsive and inhibitory or negative seizures
(Fisher, 1978; Kaplan, 1993; Lee and Lerner, 1990; Primavera
et al., 1993) and TIA with positive symptoms, such as ‘‘limb-
shaking” TIA (Fisher, 1962; Muraga, 2016). Further hampering this
distinction is the possibility of epileptic seizures caused by a TIA
(Cocito and Loeb, 1989; Ferracci et al., 2000; Primavera et al.,
1993) and the existence of other mimics with a non-vascular and
non-epileptic origin (Carreño, 2008).
De Reuck and Van Maele (De Reuck and Van Maele, 2009)
analysed the role of EEG in the differential diagnosis of a TIA versus
an inhibitory seizure and concluded that an early EEG is crucial in
their investigation. However, the type and frequency of electroen-
cephalographic abnormalities in possible TIA and its value in the
distinction between epileptic seizures and TIA is not exactly
known. In this study we aim to respond to the following:
1) What is the frequency of electroencephalographic abnor-
malities in patients with possible TIA and to which clini-
cal/imaging characteristics are they associated?
2) What is the percentage of patients with possible TIA with a
final diagnosis of epileptic seizure or definitive TIA and
which electroencephalographic characteristics differentiate
these diagnoses?
2. Methods
Prospective longitudinal study of patients with a diagnosis of
possible TIA evaluated at the TIA Clinic or admitted to the StrokeFig. 1. Study Design. TNA – Transient NeurologiUnit of the Hospital de Santa Maria (HSM-CHLN), between Novem-
ber 2010 and October 2013. The Ethics Committee ‘‘Comissão de
Ética para a Saúde” of the HSM-CHLN approved this study.
As inclusion criteria, the patients had to meet the clinical crite-
ria for an initial diagnosis of possible TIA (see definition below) and
gave their informed consent. Symptoms suggestive of brainstem/
cerebellum involvement were exclusion criteria. The study design
is described in Fig. 1.
2.1. Standardized clinical and ancillary evaluation (Correia et al.,
2015; Fonseca and Canhão, 2011)
Patients were referred to the TIA Clinic by the HSM-CHLN emer-
gency department (ED) or their family doctor. In the ED, patients
underwent routine blood tests, ECG and brain non-contrast CT scan
(CT) and were prescribed with antiplatelet agents and statins. In
the daily TIA Clinic, a stroke neurologist performed a structured
clinical interview and physical and neurological examination. On
the same day, patients underwent carotid and vertebral duplex
scans, transcranial Doppler and blood tests. Transthoracic or trans-
esophageal echocardiography or 24 h Holter were ordered, when-
ever considered necessary. When possible, an MRI including
diffusion-weighted imaging (DWI) was done. A neuroradiologist
reported all imaging exams. The stroke neurologist, after review
of all exams, decided about further treatment, the need for hospi-
talization and booked the patient for a follow-up appointment one
to three months later.
Patients with a possible TIA were admitted to the Stroke Unit,
from the ED or TIA Clinic, whenever a definitive diagnosis of TIA
was not established, symptoms had not cleared or the patient
was judged to be at a high risk of recurrence. The evaluation of
admitted patients and their follow-up was similar to those in the
TIA Clinic.
The following symptoms associated with possible TIA were sys-
tematically recorded: motor, sensory, speech disturbances, partialcal Attack/TIA – Transient Ischaemic Attack.
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fusional period. Positive symptoms were defined as the occurrence
of involuntary movements, sensory symptoms apart from numb-
ness or anaesthesia (such as tingling, stinging, prickling, burning
sensations or pain) and visual delusions (palinopsia, polyopia,
micro, macro or metaphormopsia), simple (e.g.: lights, spots, oscil-
lating lines with bright, sparkle or colour) or complex hallucina-
tions. The presence of a Jacksonian march of symptoms was
considered whenever there was sequential spread of motor (or
sensory) symptoms beginning at a specific body region to involve
other body parts, accordingly to an electrical disturbance spreading
through the homunculus of the motor (or sensory) cortex (Larner,
2011)
Patients were classified in 5 symptomatic groups, not mutually
exclusive, taking into account symptom characteristics and their
different specificity for the final diagnosis:
1. Motor symptoms
2. Positive phenomena and/or march of symptoms (more frequent
in seizures than in TIA)
3. Sensory and/or visual symptoms (posterior brain symptoms)
4. Speech disturbance
5. Amnesia for the event and/or consciousness disturbance and/or
confusional period (including consciousness, level or content,
disturbance symptoms)
2.2. Diagnostic criteria
The diagnosis of each patient was defined according to the fol-
lowing criteria:
- Initial diagnosis: established at the end of the first observation in
TIA Clinic or Stroke Unit by a stroke neurologist (PC).
- Final diagnosis: established after the end of the study by a
stroke neurologist (PC), taking into account clinical reassess-
ment 1–3 month after the clinical episode, and the result of
all diagnostic tests (including early and late EEG). Patients were
reclassified in the following final diagnosis groups: TIA; possi-
ble TIA; epileptic seizures; other TIA mimic (including
migraine; psychiatric disturbance; others). Another neurologist
trained in epilepsy (CB), having had access to the same clinical
and complementary information, independently reclassified the
patients in the same final diagnosis groups.
The following definitions were used for the diagnosis (initial
and final):
- Transient ischaemic attack (TIA): Clinical syndrome character-
ized by sudden focal neurological symptoms, presumed to be
of vascular origin, that lasted less than 24 h (WHO, 1975),
regardless of whether or not brain imaging showed a recent
ischaemic lesion. This diagnosis group included patients with
an acute onset of temporary (less than 24 h) neurological dys-
function consistent with focal brain ischemia and with support-
ive or no contradictory complementary diagnostic tests
including brain imaging demonstrating or not an acute vascular
ischemic lesion. The typical history for a TIA was a swift onset
(no symptoms to maximal symptoms in less than five minutes)
of a motor defect, sensory defect, aphasia, loss of vision in one
eye or in part of one eye, homonymous hemianopia, or a com-
bination of the above (WHO, 1975). In these patients an epilep-
tic seizure or another TIA mimic did not cause the clinical
syndrome.
- Possible transient ischaemic attack (possible TIA): Neurological
syndrome lasting less than 24 h that do not fulfil international
accepted criteria for TIA nor the criteria for a specific mimicdiagnosis, although a vascular origin could not be excluded
(Correia et al., 2015; Fonseca and Canhão, 2011). This diagnosis
group included patients with odd accompanying symptoms
(such as prickles/itching sensations, rigid postures or move-
ment of the limbs), march of symptoms, consciousness distur-
bance or amnesia with focal symptoms, multiple stereotyped
episodes, positive visual phenomena, isolated speech distur-
bance/confusion and focal symptoms plus panic or anxiety
and paucity of details in the symptoms description, (Fonseca
and Canhão, 2011) without imaging/laboratory evidence of
ischemic cerebral pathology (Kidwell and Warach, 2003) nor
of another TIA mimic.
- Transient ischaemic attack mimic (TIA mimic): Focal neurologi-
cal syndrome lasting less than 24 h, for which a non-vascular
cause was definitively established according to predefined cri-
teria (Fonseca and Canhão, 2011) (e.g.: migraine with aura)
(Headache Classification Subcommittee of the International
Headache Society, 2004), metabolic syndrome, transient global
amnesia (Caplan, 1985; Hodges and Warlow, 1990), panic
attack (American Psychiatric Association, 2000), somatoform
disorder (American Psychiatric ssociation, 2000). An epileptic
seizure can also be a TIA mimic but was classified separately
in this study.
- Epileptic seizure (seizure): transient occurrence of signs and/or
symptoms due to abnormally excessive or synchronous neu-
ronal activity in the brain (Fisher et al., 2014). This diagnosis
group included patients with positive motor, sensitive, or sen-
sorial symptoms (as previously described) and also with
motionless, unresponsive or automatic behaviour according to
stereotyped focal seizures and/or successful response to
antiepileptic treatment, epileptiform activity on EEG
(D’Ambrosio and Miller, 2010) or the occurrence of an unequiv-
ocal seizure in the follow-up. In these patients a TIA and a TIA
mimic have been excluded. Accordingly, in patients with possi-
ble TIA, the final diagnosis of seizure was established (if other
diagnoses were considered excluded after all diagnostic tests
and clinical reassessment) in two different circumstances: 1)
in patients with possible seizure semiology and epileptiform
activity in the EEG; 2) in patients with possible seizure semiol-
ogy and no epileptiform activity in the EEG but with additional
(or better described) clinical events clearly indicative of sei-
zures during the follow-up.
TIA and epileptic seizures were considered the two final diag-
noses of interest for this study.
2.3. Neurophysiological assessment
All patients underwent a 64-channel video-EEG using a digital
Nihon-Kohden device and electrodes placed in accordance with
the international 10/10 system and following national and interna-
tional recommendations (American Clinical Neurophysiology
Society, 2006a,b; Flink et al., 2002; Martins da Silva et al., 2011;
Nuwer et al., 1998) in two different periods: 1) As soon as possible
after the possible TIA (early EEG); 2) One month after (late EEG). We
intend to repeat EEG, based on guidelines reporting that repeating
EEG may be helpful when the diagnosis of epilepsy is unclear
(National Institute for Health and Care Excelence, (NICE), 2012)).
One month after the clinical event was the date chosen for EEG
repetition to match the scheduled follow-up clinical visit.
The record had a maximum duration of 60 min, including an
eye closed wake resting condition and eye open, hyperventilation
and photic stimulation manoeuvres.
Two clinical neurophysiologists (CB + RP), blinded for the final
diagnosis, interpreted the records. Discrepancies were decided by
consensus. All EEG records were evaluated for the presence of
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(Noachtar et al., 1999); asymmetry (Hirsch et al., 2013); suppres-
sion (focal, hemispheric or diffuse) (Hirsch et al., 2013); focal slow
wave activity (including focal and regional concept) (Noachtar
et al., 1999); epileptiform activity (Noachtar et al., 1999), periodic
discharges (Hirsch et al., 2013) and others.
The two EEG variables of interest for the present study were
Focal Slow Wave Activity (FSWA) and Epileptiform Activity (EA)
(Fig. 2). The following operational definitions were used:
- FSWA: continuous or intermittent slow activity i.e. theta and/or
delta band activity (Noachtar et al., 1999) limited to an area of
the brain or scalp region (includes the concept of focal and
regional (Noachtar et al., 1999)).
- EA: (Noachtar et al., 1999): transients clearly distinguishable
from background activity, with a characteristic spiky morphol-
ogy at a conventional time scale, duration of 70–200 ms (sharp
wave) or from 20 to under 70 ms (spike) and a main component
generally negative relative to other areas.
FSWA evolution between early and late EEG was also analysed
and considered ‘‘persistent” if existing in both exams (even if inter-
mittently), ‘‘transient” if present in the early but absent in the late
and ‘‘absent” if non-existent in both EEG.2.4. Statistics
Univariate descriptive statistics were used for categorical and
continuous variables. Bivariate analysis was performed using v2
test, Fisher’s exact test or t-student or Mann-Whitney test, as
appropriate. The level of significance was established at a < 0.05
(two-tailed).
To define independent predictors of neurophysiological out-
comes, significant variables at p < .05 in the bivariate analysis were
tested in multivariate analysis using a stepwise binomial logisticFig. 2. Focal SlowWave Activity and Epileptiform activity. Source derivation montage of
Black Square identifies Epileptiform Activity (abrupt wave followed by a slow wave).regression with backward elimination. A Hosmer and Lemeshow
test assessed the calibration of the model and the Receiver Opera-
tor Characteristic (ROC) curve its discriminative capacity.
As a measure of final diagnosis interobserver agreement we
used Cohen’s kappa statistic.
The statistical analysis was performed using SPSS software ver-
sion 21 for Mac.3. Results
Eighty patients were included with the initial diagnosis of pos-
sible TIA. Table 1 describes the demographic, clinical, imaging and
electroencephalographic characteristics of these patients.3.1. Frequency of EEG abnormalities
In the early EEG, 52/80 patients (65%) had FSWA, 6 of them also
EA (6/80 7.5%) and 7/80 (11.7%) other abnormalities (increase of
beta activity in 5 and diffuse slowing of background activity in
2). The EEG record was reported as normal in 21/80 patients
(26.2%).
After one month, 74 patients (92.5%) repeated the EEG, which
was normal in 25 (33.8%). In this record, 44/74 (59.5%) patients
had FSWA. FSWA evolution (Table 1) was demonstrated persistent
in 43 (58.1%), transient in 6 (8.1%) and absent in 24 (32.4%)
patients. In one patient (1.4%), FSWA only emerged in the late
EEG. Only 3 of the 6 patients with EA in the early EEG retained this
activity in the late EEG. No patient showed EA in this exam when
not present in the early EEG.
At the time of the early EEG (Supplementary file 1), 11 patients
(13.8%) were being treated with antiepileptic drugs (AED). During
follow-up, 7 patients (3 with EA in early EEG) were prescribed
AED (6 for epileptic seizures and 1 for migraine). At the time of
the late EEG, 18 patients (24.3%) were on AED.a 15 mm/s EEG page. Left Black Square highlights Focal SlowWave Activity and right
Table 1
Demographic, clinical, imaging and electroencephalographic characteristics of patients with the initial diagnosis of possible TIA.
Demographic characteristics
Male/Female 36/44 (45%/55%)
Age (Years) Mean: 65.5 (S.D. 14.4); Median: 68.5
Clinical characteristics
Sudden onset (<1 min) 54 (71.1%)
Motor symptoms 20 (25%)
Positive symptoms and/or March of symptoms 40 (50%)
Sensory symptoms and/or visual symptoms 43 (53.8%)
Speech disturbance 43 (53.8%)
Amnesia and/or consciousness disturbance and/or confusional period 36 (45%)
Number of previous episodes Mean: 2.1 (S.D. 1.3); Median: 2
Mean duration of the last episode (hours) Mean: 2.4 (S.D. 4.8); Median = 0.5
Time between symptoms and EEG (hours) Mean: 45.8 (S.D. 37.5); Median: 37.5
Imaging characteristics
MRI (n = 43/53.8%) DWI+ 4 (9.3%)
Another lesion 22 (51.2%)
Electroencephalographic characteristics
Early EEG (n = 80) FSWA 52 (65%)
EA 6 (7.5%)
Late EEG (FSWA evolution; n = 73/91.2%) Persistent FSWA 43 (58.9%)
Absent or transient FSWA 30 (41.1%)
EA – Epileptiform Activity, FSWA – Focal Slow Wave Activity, DWI+ – acute vascular lesion on MR diffusion-weighted imaging, S.D. – Standard
deviation.
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3.2.1. Age
Both patients with FSWA in the early EEG and patients with
demonstrated persistent FSWA in the late EEG were respectively
12.3 ± 3.4 (t(43.43) = 3.63, p = .001) and 11.3 ± 3.1 years (t(46.52)
= 3.66, p = .001) older than the remaining sample.
There was no significant difference in the mean age of patients
with or without EA in the EEG (t(78) = 1.17, p = .902).3.2.2. Neurological syndrome characteristics
No significant associations were found between the variables of
the two EEG and the number of previous episodes, duration or the
time interval between the clinical event and the EEG.
The electroencephalographic characteristics of the different
symptomatic groups under study are depicted in Table 2.
In the early EEG, FSWA was associated with amnesia for the
event and/or consciousness disturbance and/or a confusional per-
iod (Table 2). In this exam, 5 patients with EA (83%) had a clinical
syndrome with speech disturbances and 4 (66.7%) at least one of
the following: amnesia for the event, consciousness disturbance
and/or confusional period. EA was significant associated with a
neurological syndrome with consciousness disturbance (Fisher’s
exact test, p = .040, OR = 6.59, 95% CI: 1.11–39.15).
In the late EEG, persistent FSWA was associated with the pres-
ence of speech disturbances (v2 = 7,41, p = .006, OR = 3.77, 95% CI:
1.42–9.97) and transient FSWA with a confusional period (Fisher’s
exact test, p = .047, OR = 6,25, 95% CI: 1.04–37.37).
In a binomial logistic regression model, FSWA was no longer
predicted (p = .499, OR = 1.47, 95% CI: 1.02–1.11) by ‘‘amnesia
and/or consciousness disturbance and/or confusional period” when
adjusted for age (v2(2) = 14.00, p < .0005; NagelkerkeR2 = 22.1%;
Hosmer-Lemeshow test, p = .839; AUC = 0.74, p < .0005, 95% CI:
0.62–0.87).
Persistent FSWA in the late EEG was independent predicted by
both age (p = .002, OR = 1,08, 95% CI: 1.03–1.13) and ‘‘speech dis-
turbances” (p = .02, OR = 3.54, 95% CI: 1.22–10.28) in the logistic
regression model (v2(1) = 17.73, p < .0005; NagelkerkeR2 = 31.4%;
Hosmer-Lemeshow test, p = .714; AUC 0.80; p < .0005, 95% CI:
0.69–0.90).3.2.3. Imaging characteristics
No differences in EEG variables were observed in patients with
and without normal MRI. Among patients with an acute vascular
lesion in the MRI (DWI+), three (75%) had FSWA in the early EEG
and in two of them (66.7%) this activity disappeared in the late
EEG (Fisher’s exact test, p = .011).
3.3. Final diagnosis of epileptic seizure or definitive TIA in patients with
possible TIA
After all diagnostic tests and clinical reassessment, patients
with possible TIA were reclassified in a final diagnosis (Fig. 3).
Thirteen patients were diagnosed with epileptic seizures
(16.3%) and 11 (13.8%) with definitive TIA by the stroke neurologist
(PC). One patient had a final dual diagnosis of definitive TIA and
epileptic seizures. This patient was discharged from the Stroke Unit
with a TIA diagnosis. However, in the follow-up appointment the
patient reported different episodes that were then diagnosed as
partial complex seizures.
3.3.1. Interobserver agreement
The two neurologists agreed in the diagnosis of 59 patients
(73.8%). The interobserver concordance in the final diagnosis was
good (k = 0.627, p < .0005, 95% CI: 0.485–0.769). In the analysis
of the diagnosis of seizure (vs. non-seizure), the two classifiers
agreed in 73 patients (91.2%). The interobserver agreement was
good (k = 0.707, p < .0005, 95% CI: 0.503–0.911). Also, for the diag-
nosis of definitive TIA (vs. non definitive TIA) the interobserver
agreement was good (k = 0.789, p < .0005, 95% CI: 0.587–0.991),
with a concordant diagnosis in 76 patients (95%).
3.3.2. Clinical/Imaging characteristics associated with the final
diagnosis of interest
No significantly mean age difference was found between
patients with final diagnosis of epileptic seizures or TIA and other
final diagnosis (t(65.85) = 1.474, p = .145).
Clinical and EEG characteristics of patients with the final diag-
nosis of seizures and definitive TIA are displayed inTable 3.
Of the evaluated symptoms, only the existence of a Jacksonian









































































































































































































































































































































































































































































































































































































































































Fig. 3. Reclassification of possible TIA. *A patient classified as TIA had the
concomitant diagnosis of epileptic seizures (partial complex seizures) in the
clinical follow-up.
16 C. Bentes et al. / Clinical Neurophysiology Practice 3 (2018) 11–1950%) than in patients with definitive TIA (n = 1; 9.1%) (Fisher’s
exact test, p = .027, OR = 14.000, 95% CI: 1.329–147.429).
MRI was performed on eight (66.7%) patients with epileptic sei-
zures and five (45.4%) patients with the final diagnosis of definitive
TIA, four of whom (80%) had an acute vascular lesion in the DWI.
3.4. Electroencephalographic characteristics in patients with epileptic
seizure and definitive TIA diagnosis
FSWA in the early EEG was differently distributed between final
diagnosis groups (p = .027). Furthermore, FSWA in the early EEG
was associated with the final diagnosis of epileptic seizure or
definitive TIA compared to other type of final diagnosis (19/23
patients versus 33/57 patients; p = .041; OR 3.46; 95% CI 1.04–
11.46).
The only significant EEG difference between patients with
epileptic seizures and definitive TIA was a different evolution of
FSWA between the early and the late EEG (Table 3). The chance
of persistent FSWA in the late EEG was significantly greater (13.2
times higher) in a patient with an epileptic seizure than in a
patient with TIA. In fact, the majority of patients with seizures
(91.7%) maintained the FSWA between the two examinations
while the same only occurred in less than half (45.5%) of TIA
patients. Furthermore, absent or transitory FSWAwas less frequent
in patients with seizures (8.3%) than with TIA (54.5%).
Although a higher percentage of patients with epileptic seizures
had EA, this difference was not statistically significant. Of the 13
patients who had the final diagnosis of epileptic seizures, six
(46.2%) had EA in the early EEG.
4. Discussion
FSWA was the commonest EEG abnormality found in the early
EEG of patients with possible TIA, but did not distinguish between
TIA and seizure patients. In patients with seizures, FSWA was more
common than epileptiform activity and its presence in the EEG one
month later was more likely in patients with epileptic seizures.
In this work, EEG abnormalities were frequent, occurring in
73.8% of the patients. FSWA was the most common, although
others could be identified. This percentage is similar to that found
by De Reuck and Van Maele (2009) in patients with inhibitory sei-
zures (76%), but rather different from that of patients with defini-
Table 3
Clinical characteristics of the patients with a final diagnosis of seizures and TIA.
Final diagnosis p
Seizures* (n = 12) TIA* (n = 11)
Age in years (SD) 68.2 (10.4) 68.9 (9.1) .874
Total duration of symptoms in hours (SD) 1.3 (1.5) 1.8 (2.6) .695
Number of previous episodes (SD) 2.8 (1.8) 2.4 (1.6) .874
Time between symptoms and EEG in hours (SD) 34.6 (32.3) 38.2 (26.1) .561
Symptoms p, OR, 95% CI
Motor symptoms 4 (33.3%) 6 (54.5%) .414 0.417, 0.08–2.25
Positive symptoms and/or March of symptoms 7 (58.3%) 3 (27.3%) .214 3.73, 0.65–21.58
Sensory and/or visual symptoms 3 (25%) 5 (45.4%) .400 0.40, 0.07–2.34
Speech disturbances 8 (66.7%) 8 (72.7%) 1.000 0.75, 0.12–4.49
Amnesia and/or Consciousness disturbance and/or Confusional period 7 (58.3%) 5 (45.4%) .537 1.68, 0.32–8.76
Electroencephalographic characteristics
Early EEG FSWA 11 (91.7%) 8 (72.7%) .317 4.12, 0.36–47.30
EA 5 (41.7%) 1 (9.1%) .1557.14, 0.68–75.22
Late EEG (FSWA evolution) Persistent FSWA 11 (91.7%) 5 (45.4%) .027 13.20, 1.24–140.68
Absent or transient FSWA 1 (8.3%) 6 (54.5%)
EA – Epileptiform Activity, FSWA – Focal Slow Wave Activity, TIA – Transient Ischaemic Attack.
* The patient who had the final dual diagnosis of TIA and seizures is included in this table only in the TIA group because the clinical episode that provoked the admission to
the Stroke Unit had the final diagnosis of TIA.
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not recognise early EEG differences between epileptic seizure and
definitive TIA patients. There are some plausible explanations for
this apparent discrepancy between the two studies, namely time
until EEG and age. Neurological syndromes lasting less than 24 h
are, by definition, time-limited events of neurological dysfunction
and, for that reason, time interval between clinical manifestations
and EEG might influence the presence or the type of electroen-
cephalographic abnormalities. In the De Reuch and Van Maele
study, 100% of patients with seizures but less than half of patients
with definitive TIA underwent an EEG in the first 24 h. Further-
more, temporal slowing is a frequent finding in older patients
(Samson-Dollfus et al., 1991) and seizure patients were older than
TIA patients in the same study. In our series, time until EEG and
age were not significantly different in patients with seizures and
with TIA.
In this series of possible TIA patients, epileptic seizures were the
most common final diagnosis, followed by definitive TIA. Approxi-
mately one half of the patients remained undiagnosed, clearly
showing the differential diagnosis difficulty of possible TIA and
the need for complementary strategies supporting the classifica-
tion of these undefined events (Dolmans et al., 2015). Sequential
spread of symptoms according to the homunculus of the motor
(or sensory) cortex were associated with the diagnosis of epileptic
seizures, in agreement with the ‘‘Jacksonian march” characteristic
of focal seizures (York and Steinberg, 2011).
In our work, patients with early FSWA had a higher probability
of subsequent diagnosis of epileptic seizures or definitive TIA, not
explained by a different mean age between final diagnosis groups.
Furthermore, a higher percentage of patients with these final diag-
noses had early FSWA compared to early EA (82.6% vs. 26.1%,
respectively). Although FSWA is not specific to the final diagnosis,
it was informative and more sensitive than EA. In line with these
results, a patient with a possible TIA with early FSWA should be
further investigated and followed-up.
Six patients (7.5%) had EA in the early EEG, a higher percentage
than the reported frequency of false-positive (0.5–1%) in asymp-
tomatic individuals (Gregory et al., 1993; Robin et al., 1978). The
percentage of patients with a definite diagnosis of epileptic sei-
zures and EA in the early EEG (46.2%) is within the range of sensi-
tivity reported for EEG (26 to 56%) as a diagnosis test for epilepsy
(National Institute for Health and Care Excelence, (NICE), 2012).
Still, it is possible that AED prescription in 14% of the patients
reduced the probability of finding EA in the early EEG (Jawadet al., 1986; Milligan et al., 1982; Pro et al., 2009; Rocamora
et al., 2006). Furthermore, focal seizures arising from small foci
or deep foci for the recording electrodes may not have a surface
EEG correlate. It is known that the repetition of EEG can be useful
when the diagnosis of epilepsy is not clear (National Institute for
Health and Care Excelence, (NICE), 2012; Scottish Intercollegiate
Guidelines Network, 2015). Salinsky and collaborators (Salinsky
et al., 1987) showed that 50% of epilepsy patients had EA in the
first EEG, 84% in the third EEG and 92% in the fourth EEG. However,
in our study, the repetition of the EEG did not improve the EEG
value in EA detection, as would be expected. There are two possible
reasons for this finding. On the one hand, there is the already dis-
cussed effect of AED in the intercritical EA (Jawad et al., 1986;
Milligan et al., 1982; Pro et al., 2009; Rocamora et al., 2006). In fact,
the percentage of medicated epileptic seizures patients by the time
of late EEG was greater than in early EEG (92.3%. vs. 38.5%). On the
other hand, the likelihood of finding EA in the EEG seems to
decrease over time after a paroxysmal event (Sundaram et al.,
1990). The lack of a significant difference in the incidence of EA
in the EEG of patients with the final diagnosis of seizure and TIA
is likely to be due to small patient numbers in each subgroup.
The time evolution pattern of FSWA was significantly different
between the two final diagnostic groups (seizures and TIA), as
patients with seizures more often had FSWA persisting in the late
EEG. The high percentage of epileptic seizure patients with early
FSWA and the persistence of FSWA in the late EEG in these
patients, may represent a neurophysiologic marker of the existence
of an enduring predisposition to generate epileptic seizures (Fisher
et al., 2005, 2014). In fact, FSWA has been described in patients
with epilepsy as a good marker of the epileptogenic network and
the ictal onset zone (Brigo, 2011; Di Gennaro et al., 2003; Tao
et al., 2011; Vanrumste et al., 2005). In contrast, patients with
definitive TIA had a different FSWA time evolution pattern: either
they never had FSWA in the early EEG or the FSWA was no longer
present in the late EEG, in accordance with what was described in
transitory cerebral ischemia due to carotid compression (Meyer
et al., 1965).
This work has some strengths, such as: 1) it compares EEG dif-
ferences between patients who initially had transient neurological
symptoms and a not yet established neurological diagnosis, reflect-
ing the clinical practice diagnostic question - is the EEG useful
when the diagnose is unknown?; 2) EEG readers were blind to
the final diagnosis, which was established only after the EEG
report; 3) no patients were lost for clinical follow-up and only a
18 C. Bentes et al. / Clinical Neurophysiology Practice 3 (2018) 11–19few (7.7%) for the EEG follow-up; and 4) the high final diagnosis
interobserver agreement gives robustness to the results. Neverthe-
less, this study also has some limitations, in particular: 1) it was
hospital-based limiting generalization to other clinical settings;
2) A time-based TIA definition was used, so these results may
not apply to tissue-based defined TIA (Albers et al., 2002; Easton
et al., 2009); 3) Only two EEG abnormalities were variables of
interest in this study but others could be considered; 4) the sample
size was modest, which limits the statistical power for some
comparisons.
5. Conclusions
In the early EEG, the majority (58.3%) of patients with a final
diagnosis of an epileptic seizure did not have EA. FSWA in the early
EEG occurred whether the patient suffered a seizure or TIA (and
was more often present than EA following a seizure), but in the
EEG performed 1 month after the clinical episode was more likely
to indicate that the initial event was a seizure.
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